Nasdaq biol.

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that the Company has been awarded a Top Workplaces 2022 honor by the Orange County Register Top Workplaces. The ...

Nasdaq biol. Things To Know About Nasdaq biol.

Dental technology company Sonendo ( NYSE: SONX) on Wednesday said its unit PIPStek had filed a patent infringement lawsuit against maker of dental lasers Biolase ( NASDAQ: BIOL ). The lawsuit was ...Feb 1, 2021 · FOOTHILL RANCH, Calif., Feb. 1, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, encourages stockholders to vote their shares with respect to the adjourned ... BIOLASE, Inc. (NASDAQ:BIOL) fell 10% to $1.35 in pre-market trading. Biolase shares jumped 44% on Tuesday after the company announced Q4 preliminary sales guidance above analyst estimates..At just 47 cents a share, BIOL stock is in danger of being delisted by the Nasdaq, which requires companies to maintain a minimum share price of $1 to remain on the exchange. However, in a news ...BIOLASE, Inc. (NASDAQ:BIOL) was down, falling 38% to $2.0095 after the company announced pricing of a $4.5 million underwritten public offering of Series J Convertible Redeemable Preferred Stock ...

FOOTHILL RANCH, Calif., Jan. 6, 2022 /PRNewswire/-- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and EdgeEndo, a global leader in commercializing endodontic products ...

Mar 1, 2022 · 01 Mar, 2022, 16:15 ET. FOOTHILL RANCH, Calif., March 1, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced that its Board of Directors ...

LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten ...2 analysts have issued 1-year price objectives for BIOLASE's shares. Their BIOL share price targets range from $4.00 to $150.00. On average, they anticipate the company's stock price to reach $77.00 in the next year. …/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it will be presenting at the Benchmark Company Discovery...Biolase, Inc. is estimated to report earnings on 11/09/2022. The upcoming earnings date is derived from an algorithm based on a company's historical reporting …

BIOL stock is up 44% year-to-date, but it’s literally a penny stock trading at about 70 cents a share, with a $101 million market cap. The stock has a B-rating in my Portfolio Grader . Best ...

Nov 22, 2023 · BIOL Biolase Inc Statement of Ownership (sc 13g) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction ...

IRVINE, Calif., July 2, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced that the subscription period for the rights offering has commenced. If ...FOOTHILL RANCH, Calif., Jan. 18, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that based on currently available information, preliminary ...IRVINE, Calif., Oct. 9, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced that Dr. Elaine C. Wagner, a retired Rear Admiral with 33 years of ...The latest price target for . Biolase (NASDAQ: BIOL) was reported by Lake Street on May 31, 2023.The analyst firm set a price target for $0.40 expecting BIOL to fall to within 12 months (a ...Graphite Bio, Inc. (Nasdaq – GRPH) Under the terms of the agreement, Graphite Bio will merge with LENZ Therapeutics in an all-stock transaction. Under the …An analysis of the stock market reaction to the announcements of the UK Soft Drinks Industry Levy. Econ Hum Biol. 2020 Aug:38:100834. doi: 10.1016/j.ehb ...

At just 47 cents a share, BIOL stock is in danger of being delisted by the Nasdaq, which requires companies to maintain a minimum share price of $1 to remain on the exchange. However, in a news ...Home BIOL • NASDAQ BIOLASE Inc Follow Share $1.15 Dec 1, 8:30:00 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to T2 Biosystems Inc $3.90 TTOO10.17% Assertio Holdings Inc $1.14... FOOTHILL RANCH, Calif., March 23, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that President and CEO, John Beaver, has been invited to ...At just 47 cents a share, BIOL stock is in danger of being delisted by the Nasdaq, which requires companies to maintain a minimum share price of $1 to remain on the exchange. However, in a news ...BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and EdgeEndo, a global leader in commercializing endodontic products, announced the FDA 510(k) clearance of the Ed gePRO system for endodontists seeking a more effective cleaning and disinfection alternative within root canal procedures. The new laser …

LAKE FOREST, Calif., June 6, 2022 /PRNewswire/ -- To further accelerate the adoption of lasers as the gold standard of care in dentistry, BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental ...BIOLASE, Inc. (NASDAQ:BIOL) rose 10% to close at $0.5775 after gaining 9% on Friday. The company, last month, was granted US patent for 'Dental laser interface system and method.'

FOOTHILL RANCH, Calif., Feb. 10, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), a global leader in dental lasers, today announced the closing of its previously announced bought deal offering ...BIOLASE, Inc. (NASDAQ:BIOL) said its second-quarter revenues climbed 2.11% to $9.1 million. The company reported break-even results as opposed to the loss of 12 cents per share a year earlier. The ...LAKE FOREST, Calif. , Nov. 9, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial …01 Mar, 2022, 16:15 ET. FOOTHILL RANCH, Calif., March 1, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced that its Board of Directors ...Biolase, Inc. Common Stock (BIOL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Aug 14, 2021 · You can click the graphic below for the historical numbers, but it shows that BIOLASE had US$13.1m of debt in June 2021, down from US$16.7m, one year before. However, its balance sheet shows it ... Nasdaq +78.81(+0.55%) Russell 2000 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) BIOLASE, Inc. (BIOL) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W...IRVINE, Calif., July 9, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that BIOLASE CEO Todd Norbe has been invited to participate in a ...FOOTHILL RANCH, Calif., April 20, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and EdgeEndo, a global leader in commercializing endodontic products, announced in association with the American Association of Endodontists (AAE) Annual Meeting beginning on April 21, 2021, the co …Dec 1, 2023 · Short selling BIOL is an investing strategy that aims to generate trading profit from BIOLASE as its price is falling. BIOL shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender.

May 11, 2023 · LAKE FOREST, Calif., May 11, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the first quarter ended March 31, 2023 ...

Biolase (NASDAQ:BIOL) has filed to offering 125,000 unites, each consisting of:One Share of Series J Convertible Preferred Stock with a Liquidation Preference of $100.00 and One Warrant to... Investing.com; Aug 30, 2023 21:35

According to the recent notification letter, the staff of NASDAQ has determined that for the last ten consecutive business days, from January 21, 2021 to February 3, 2021, the closing bid price of ...Dec 1, 2023 · BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants. LAKE FOREST, Calif. , Sept. 13, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public ... BIOLASE Stock Performance. Shares of BIOL stock opened at $1.25 on Tuesday. The company has a quick ratio of 0.71, a current ratio of 1.40 and a debt-to-equity ratio of 34.06. The firm has a 50 day moving average price of $1.78 and a two-hundred day moving average price of $11.22. BIOLASE has a 12-month low of $1.07 and a 12-month high of $175.99.The BIOL share has a YTD performance of -22% and a 52-week price range of $0.37 - $10.4. The stock has experienced positive momentum due to a solid revenue report in Q4 2022. With a stock price below $1, the stock may provide great value to investors considering a positive outlook for 2023. Best place to buy BIOL: RobinhoodHedge fund interest in ENGlobal Corp (NASDAQ: ENG) shares was flat at the end of last quarter. This is usually a negative indicator. Our calculations also showed that ENG isn't among the 30 most ...Feb 4, 2021 · According to the recent notification letter, the staff of NASDAQ has determined that for the last ten consecutive business days, from January 21, 2021 to February 3, 2021, the closing bid price of ... Nov 29, 2023 · BIOLASE (NASDAQ:BIOL) and ReShape Lifesciences (NASDAQ:RSLS) are both small-cap medical companies, but which is the superior investment?We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, community ranking, analyst recommendations and profitability. May 11, 2023 · LAKE FOREST, Calif., May 11, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the first quarter ended March 31, 2023 ... LAKE FOREST, Calif., June 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it has entered into a securities purchase agreement with a ...

Jan 31, 2023 · Find the latest on short interest for Biolase, Inc. Common Stock (BIOL) at Nasdaq.com. Biolase Inc (NASDAQ:BIOL) is the most popular stock in this table. On the other hand WVS Financial Corp. (NASDAQ:WVFC) is the least popular one with only 1 bullish hedge fund positions.Dental technology company Sonendo ( NYSE: SONX) on Wednesday said its unit PIPStek had filed a patent infringement lawsuit against maker of dental lasers Biolase ( NASDAQ: BIOL ). The lawsuit was ...Instagram:https://instagram. ag stocksforex broker listpioneer energy stocktggl stock 17 Nov, 2020, 09:00 ET. IRVINE, Calif., Nov. 17, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, completed its leadership council meeting of the Waterlase ...Nov 10, 2023 · Biolase (BIOL) stock is flying high on Tuesday after announcing a massive deal for its dental lasers with Dental Care Alliance. BIOLASE down 30%, prices $4.5M stock offering (NASDAQ:BIOL) From ... nvda support and resistanceeli lilly stock chart Biolase (NASDAQ: BIOL) stock is taking a beating on Friday following the release of its earnings report for the first quarter of 2023. The bad news for investors in BIOL stock is the company’s ... best stock charting software FOOTHILL RANCH, Calif., Feb. 10, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), a global leader in dental lasers, today announced the closing of its previously announced bought deal offering ...BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 175,000 units (the "Units"), with ...What is BIOLASE's consensus rating and price target? According to the issued ratings of 2 analysts in the last year, the consensus rating for BIOLASE stock is Buy based on the current 2 buy ratings for BIOL. The average twelve-month price prediction for BIOLASE is $77.00 with a high price target of $150.00 and a low price target of $4.00.